Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Predictive factors for lumacaftor/ivacaftor clinical response.

Masson A, Schneider-Futschik EK, Baatallah N, Nguyen-Khoa T, Girodon E, Hatton A, Flament T, Le Bourgeois M, Chedevergne F, Bailly C, Kyrilli S, Achimastos D, Hinzpeter A, Edelman A, Sermet-Gaudelus I.

J Cyst Fibros. 2019 May;18(3):368-374. doi: 10.1016/j.jcf.2018.12.011. Epub 2018 Dec 28.

PMID:
30595473
2.

Prognostic factors of disease severity in infants with sickle cell anemia: A comprehensive longitudinal cohort study.

Brousse V, El Hoss S, Bouazza N, Arnaud C, Bernaudin F, Pellegrino B, Guitton C, Odièvre-Montanié MH, Mames D, Brouzes C, Picard V, Nguyen-Khoa T, Pereira C, Lapouméroulie C, Pissard S, Gardner K, Menzel S, Le Van Kim C, Colin-Aronovicz Y, Buffet P, Mohandas N, Elie C, Maier-Redelsperger M, El Nemer W, de Montalembert M.

Am J Hematol. 2018 Nov;93(11):1411-1419. doi: 10.1002/ajh.25260. Epub 2018 Sep 21.

PMID:
30132969
3.

Comparative proteomics of respiratory exosomes in cystic fibrosis, primary ciliary dyskinesia and asthma.

Rollet-Cohen V, Bourderioux M, Lipecka J, Chhuon C, Jung VA, Mesbahi M, Nguyen-Khoa T, Guérin-Pfyffer S, Schmitt A, Edelman A, Sermet-Gaudelus I, Guerrera IC.

J Proteomics. 2018 Aug 15;185:1-7. doi: 10.1016/j.jprot.2018.07.001. Epub 2018 Jul 3.

PMID:
30032860
4.

Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.

Nguyen-Khoa T, Mine L, Allaf B, Ribeil JA, Remus C, Stanislas A, Gauthereau V, Enouz S, Kim JS, Yang X, Gluckman E, Beaudeux JL, Munnich A, Girot R, Cavazzana M.

Ann Biol Clin (Paris). 2018 Aug 1;76(4):416-420. doi: 10.1684/abc.2018.1354.

PMID:
29976532
5.

Guidelines for the clinical management and follow-up of infants with inconclusive cystic fibrosis diagnosis through newborn screening.

Sermet-Gaudelus I, Brouard J, Audrézet MP, Couderc Kohen L, Weiss L, Wizla N, Vrielynck S, LLerena K, Le Bourgeois M, Deneuville E, Remus N, Nguyen-Khoa T, Raynal C, Roussey M, Girodon E.

Arch Pediatr. 2017 Dec;24(12):e1-e14. doi: 10.1016/j.arcped.2017.07.015. Epub 2017 Nov 22.

PMID:
29174009
6.

Mycophenolate Mofetil and Rapamycin Induce Apoptosis in the Human Monocytic U937 Cell Line Through Two Different Pathways.

Nowak M, Tardivel S, Nguyen-Khoa T, Abreu S, Allaoui F, Fournier N, Chaminade P, Paul JL, Lacour B.

J Cell Biochem. 2017 Oct;118(10):3480-3487. doi: 10.1002/jcb.26007. Epub 2017 Apr 24.

PMID:
28345768
7.

[Management of infants whose diagnosis is inconclusive at neonatal screening for cystic fibrosis].

Sermet-Gaudelus I, Brouard J, Audrézet MP, Couderc Kohen L, Weiss L, Wizla N, Vrielynck S, LLerena K, Le Bourgeois M, Deneuville E, Remus N, Nguyen-Khoa T, Raynal C, Roussey M, Girodon E.

Arch Pediatr. 2017 Apr;24(4):401-414. doi: 10.1016/j.arcped.2017.01.019. Epub 2017 Mar 1. French.

PMID:
28258861
8.

Changes of CFTR functional measurements and clinical improvements in cystic fibrosis patients with non p.Gly551Asp gating mutations treated with ivacaftor.

Mesbahi M, Shteinberg M, Wilschanski M, Hatton A, Nguyen-Khoa T, Friedman H, Cohen M, Escabasse V, Le Bourgeois M, Lucidi V, Sermet-Gaudelus I, Bassinet L, Livnat G.

J Cyst Fibros. 2017 Jan;16(1):45-48. doi: 10.1016/j.jcf.2016.08.006. Epub 2016 Sep 20.

9.

Benefits of new immunoglobulin-derived biomarkers for the diagnosis and follow-up of patients with dysglobulinemia.

Ermak N, Nguyen-Khoa T, Alyanakian MA.

Ann Biol Clin (Paris). 2016 Oct 1;74(5):597-605. Review.

10.

Plasma and intraprostatic concentrations of ertapenem following preoperative single dose administration: a single-centre prospective experience and clinical implications-the ERTAPRO study.

Dariane C, Amin A, Lortholary O, Lalli A, Michel C, Le Guilchet T, Treluyer JM, Nguyen-Khoa T, De Toma C, Urien S, Méjean A, Bourget P, Timsit MO.

Int J Antimicrob Agents. 2016 Aug;48(2):168-74. doi: 10.1016/j.ijantimicag.2016.04.027. Epub 2016 Jun 2.

PMID:
27324263
11.

Insulin regimens, diabetes knowledge, quality of life, and HbA1c in children and adolescents with type 1 diabetes.

Keller M, Attia R, Beltrand J, Djadi-Prat J, Nguyen-Khoa T, Jay JP, Cahané M, Choleau C, Robert JJ.

Pediatr Diabetes. 2017 Aug;18(5):340-347. doi: 10.1111/pedi.12397. Epub 2016 May 10.

PMID:
27161814
12.

Concentrations plasmatiques et intra-prostatiques d'ertapénème après administration préopératoire : expérience prospective monocentrique - étude ERTAPRO.

Dariane C, Amin A, Lortholary O, Lalli A, Michel C, Le Guilchet T, Treluyer J, Nguyen-Khoa T, De Toma C, Urien S, Méjean A, Bourget P, Timsit M.

Prog Urol. 2015 Nov;25(13):775. doi: 10.1016/j.purol.2015.08.121. French. No abstract available.

PMID:
26544316
13.

A new workflow for proteomic analysis of urinary exosomes and assessment in cystinuria patients.

Bourderioux M, Nguyen-Khoa T, Chhuon C, Jeanson L, Tondelier D, Walczak M, Ollero M, Bekri S, Knebelmann B, Escudier E, Escudier B, Edelman A, Guerrera IC.

J Proteome Res. 2015 Jan 2;14(1):567-77. doi: 10.1021/pr501003q. Epub 2014 Nov 12.

PMID:
25365230
14.

[Sweat chloride measurement using direct potentiometry: Spotchem(®) (Elitech-Arkray) evaluation and comparison with coulometry and conductivity].

Nguyen-Khoa T, Borgard JP, Miled R, Rota M.

Ann Biol Clin (Paris). 2013 Jul-Aug;71(4):443-8. doi: 10.1684/abc.2013.0866. French.

15.

Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice.

Nikolov IG, Joki N, Galmiche A, Nguyen-Khoa T, Guerrera IC, Guillonneau F, Ivanovski O, Phan O, Maizel J, Marçon F, Benchitrit J, Lucas A, Edelman A, Lacour B, Drüeke TB, Massy ZA.

Atherosclerosis. 2013 Jul;229(1):42-51. doi: 10.1016/j.atherosclerosis.2013.02.041. Epub 2013 Apr 22.

PMID:
23672878
16.

CFTR biomarkers: time for promotion to surrogate end-point.

De Boeck K, Kent L, Davies J, Derichs N, Amaral M, Rowe SM, Middleton P, de Jonge H, Bronsveld I, Wilschanski M, Melotti P, Danner-Boucher I, Boerner S, Fajac I, Southern K, de Nooijer RA, Bot A, de Rijke Y, de Wachter E, Leal T, Vermeulen F, Hug MJ, Rault G, Nguyen-Khoa T, Barreto C, Proesmans M, Sermet-Gaudelus I; European Cystic Fibrosis Society Clinical Trial Network Standardisation Committee.

Eur Respir J. 2013 Jan;41(1):203-16. doi: 10.1183/09031936.00057512. Epub 2012 Aug 9. Review.

17.

[Analytical quality of assays and comparison of procedures for the sweat test].

Nguyen-Khoa T, Borgard JP, Marchand M, Sitruk-Khalfon D, Feuillet MN, Feldmann D, Vassault A, Rota M.

Ann Biol Clin (Paris). 2012 Jan-Feb;70(1):5-12. doi: 10.1684/abc.2011.0650. French.

18.

Oxidative stress induces unfolding protein response and inflammation in nasal polyposis.

Jeanson L, Kelly M, Coste A, Guerrera IC, Fritsch J, Nguyen-Khoa T, Baudouin-Legros M, Papon JF, Zadigue P, Prulière-Escabasse V, Amselem S, Escudier E, Edelman A.

Allergy. 2012 Mar;67(3):403-12. doi: 10.1111/j.1398-9995.2011.02769.x. Epub 2011 Dec 22.

PMID:
22188019
19.

Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.

Nikolov IG, Joki N, Nguyen-Khoa T, Guerrera IC, Maizel J, Benchitrit J, Machado dos Reis L, Edelman A, Lacour B, Jorgetti V, Drüeke TB, Massy ZA.

Nephrol Dial Transplant. 2012 Feb;27(2):505-13. doi: 10.1093/ndt/gfr254. Epub 2011 Jun 24.

PMID:
21705467
20.

GSH monoethyl ester rescues mitochondrial defects in cystic fibrosis models.

Kelly-Aubert M, Trudel S, Fritsch J, Nguyen-Khoa T, Baudouin-Legros M, Moriceau S, Jeanson L, Djouadi F, Matar C, Conti M, Ollero M, Brouillard F, Edelman A.

Hum Mol Genet. 2011 Jul 15;20(14):2745-59. doi: 10.1093/hmg/ddr173. Epub 2011 Apr 25.

PMID:
21518732
21.

Cardiac glycosides ouabain and digoxin interfere with the regulation of glutamate transporter GLAST in astrocytes cultured from neonatal rat brain.

Nguyen KT, Buljan V, Else PL, Pow DV, Balcar VJ.

Neurochem Res. 2010 Dec;35(12):2062-9. doi: 10.1007/s11064-010-0274-4. Epub 2010 Oct 2.

22.

[French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening].

Sermet-Gaudelus I, Munck A, Rota M, Roussey M, Feldmann D, Nguyen-Khoa T; Groupe de travail "Dépistage néonatal" de la Fédération des centres de ressources et de compétences de la mucoviscidose.

Arch Pediatr. 2010 Sep;17(9):1349-58. doi: 10.1016/j.arcped.2010.06.021. Epub 2010 Aug 16. French. Erratum in: Arch Pediatr. 2010 Dec;17(12):1730. Nguyen-Khoa, T [added].

PMID:
20719482
23.

Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure.

Nikolov IG, Joki N, Nguyen-Khoa T, Ivanovski O, Phan O, Lacour B, Drüeke TB, Massy ZA, Dos Reis LM, Jorgetti V, Lafage-Proust MH.

Bone. 2010 Jul;47(1):156-63. doi: 10.1016/j.bone.2010.04.600. Epub 2010 Apr 18.

PMID:
20406703
24.

Cystic fibrosis transmembrane regulator inhibitors CFTR(inh)-172 and GlyH-101 target mitochondrial functions, independently of chloride channel inhibition.

Kelly M, Trudel S, Brouillard F, Bouillaud F, Colas J, Nguyen-Khoa T, Ollero M, Edelman A, Fritsch J.

J Pharmacol Exp Ther. 2010 Apr;333(1):60-9. doi: 10.1124/jpet.109.162032. Epub 2010 Jan 5.

PMID:
20051483
25.

Peroxiredoxin 6 fails to limit phospholipid peroxidation in lung from Cftr-knockout mice subjected to oxidative challenge.

Trudel S, Kelly M, Fritsch J, Nguyen-Khoa T, Thérond P, Couturier M, Dadlez M, Debski J, Touqui L, Vallée B, Ollero M, Edelman A, Brouillard F.

PLoS One. 2009 Jun 29;4(6):e6075. doi: 10.1371/journal.pone.0006075.

26.

Rottlerin inhibits (Na+, K+)-ATPase activity in brain tissue and alters D-aspartate dependent redistribution of glutamate transporter GLAST in cultured astrocytes.

Nguyen KT, Shin JW, Rae C, Nanitsos EK, Acosta GB, Pow DV, Buljan V, Bennett MR, Else PL, Balcar VJ.

Neurochem Res. 2009 Oct;34(10):1767-74. doi: 10.1007/s11064-009-9996-6. Epub 2009 Jun 3.

PMID:
19495968
27.

Distribution of glutamate transporter GLAST in membranes of cultured astrocytes in the presence of glutamate transport substrates and ATP.

Shin JW, Nguyen KT, Pow DV, Knight T, Buljan V, Bennett MR, Balcar VJ.

Neurochem Res. 2009 Oct;34(10):1758-66. doi: 10.1007/s11064-009-9982-z. Epub 2009 May 8.

PMID:
19440835
28.

The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice.

Ivanovski O, Nikolov IG, Joki N, Caudrillier A, Phan O, Mentaverri R, Maizel J, Hamada Y, Nguyen-Khoa T, Fukagawa M, Kamel S, Lacour B, Drüeke TB, Massy ZA.

Atherosclerosis. 2009 Jul;205(1):55-62. doi: 10.1016/j.atherosclerosis.2008.10.043. Epub 2008 Nov 18.

PMID:
19118829
29.

Glutathione S-transferases related to P. aeruginosa lung infection in cystic fibrosis children: preliminary study.

Feuillet-Fieux MN, Nguyen-Khoa T, Loriot MA, Kelly M, de Villartay P, Sermet I, Verrier P, Bonnefont JP, Beaune P, Lenoir G, Lacour B.

Clin Biochem. 2009 Jan;42(1-2):57-63. doi: 10.1016/j.clinbiochem.2008.09.116. Epub 2008 Oct 17.

PMID:
18976645
30.

[Measurement of pulmonary inflammation in cystic fibrosis].

Fayon M, Chiron R, Abely M; pour le Groupe "Inflammation" de la Société Française de la Mucoviscidose.

Rev Mal Respir. 2008 Jun;25(6):705-24. Review. French.

PMID:
18772828
31.

[Sweat testing: review of technical requirements].

Rota M, Nguyen-Khoa T, Marchand M, Feldmann D, Dumont J, Khalfon D, Vassault A, Borgard JP; Groupe de travail Test de la sueur du Collège national de biochimie des hôpitaux.

Ann Biol Clin (Paris). 2008 Mar-Apr;66(2):221-7. doi: 10.1684/abc.2008.0214. French.

32.

Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.

Ivanovski O, Szumilak D, Nguyen-Khoa T, Nikolov IG, Joki N, Mothu N, Maizel J, Westenfeld R, Ketteler M, Lacour B, Drüeke TB, Massy ZA.

J Urol. 2008 Apr;179(4):1631-6. doi: 10.1016/j.juro.2007.11.042. Epub 2008 Mar 4.

PMID:
18295249
33.

Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure.

Phan O, Ivanovski O, Nikolov IG, Joki N, Maizel J, Louvet L, Chasseraud M, Nguyen-Khoa T, Lacour B, Drüeke TB, Massy ZA.

Nephrol Dial Transplant. 2008 Jan;23(1):82-90. Epub 2007 Oct 31.

PMID:
17977878
34.

Plasma-induced endothelial oxidative stress is related to the severity of septic shock.

Huet O, Obata R, Aubron C, Spraul-Davit A, Charpentier J, Laplace C, Nguyen-Khoa T, Conti M, Vicaut E, Mira JP, Duranteau J.

Crit Care Med. 2007 Mar;35(3):821-6.

PMID:
17255877
35.

Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.

Bauvois B, Mothu N, Nguyen J, Nguyen-Khoa T, Nöel LH, Jungers P.

Nephrol Dial Transplant. 2007 Apr;22(4):1115-22. Epub 2007 Jan 5.

PMID:
17205957
36.

Reg2 inactivation increases sensitivity to Fas hepatotoxicity and delays liver regeneration post-hepatectomy in mice.

Lieu HT, Simon MT, Nguyen-Khoa T, Kebede M, Cortes A, Tebar L, Smith AJ, Bayne R, Hunt SP, Bréchot C, Christa L.

Hepatology. 2006 Dec;44(6):1452-64.

PMID:
17133485
37.

[Continued late referral of patients with chronic kidney disease. Causes, consequences, and approaches to improvement].

Jungers P, Joly D, Nguyen-Khoa T, Mothu N, Bassilios N, Grünfeld JP.

Presse Med. 2006 Jan;35(1 Pt 1):17-22. French.

38.

Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment.

Weissinger EM, Nguyen-Khoa T, Fumeron C, Saltiel C, Walden M, Kaiser T, Mischak H, Drüeke TB, Lacour B, Massy ZA.

Proteomics. 2006 Feb;6(3):993-1000.

PMID:
16372263
39.

Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.

Phan O, Ivanovski O, Nguyen-Khoa T, Mothu N, Angulo J, Westenfeld R, Ketteler M, Meert N, Maizel J, Nikolov IG, Vanholder R, Lacour B, Drüeke TB, Massy ZA.

Circulation. 2005 Nov 1;112(18):2875-82.

PMID:
16267260
40.

Glutamatergic hypothesis of schizophrenia: involvement of Na+/K+-dependent glutamate transport.

Nanitsos EK, Nguyen KT, St'astný F, Balcar VJ.

J Biomed Sci. 2005 Dec;12(6):975-84. Epub 2005 Oct 14. Review.

PMID:
16228297
41.

Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients.

Fumeron C, Nguyen-Khoa T, Saltiel C, Kebede M, Buisson C, Drüeke TB, Lacour B, Massy ZA.

Nephrol Dial Transplant. 2005 Sep;20(9):1874-9. Epub 2005 Jun 21.

PMID:
15972322
42.

Dietary salt restriction accelerates atherosclerosis in apolipoprotein E-deficient mice.

Ivanovski O, Szumilak D, Nguyen-Khoa T, Dechaux M, Massy ZA, Phan O, Mothu N, Lacour B, Drueke TB, Muntzel M.

Atherosclerosis. 2005 Jun;180(2):271-6. Epub 2005 Jan 19.

PMID:
15910852
43.

The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice.

Ivanovski O, Szumilak D, Nguyen-Khoa T, Ruellan N, Phan O, Lacour B, Descamps-Latscha B, Drüeke TB, Massy ZA.

Kidney Int. 2005 Jun;67(6):2288-94.

44.

Dysregulation of superoxide dismutase in chronic kidney disease.

Kelly M, Lacour B, Nguyen-Khoa T.

Nephron Clin Pract. 2005;100(3):c103-4. Epub 2005 Apr 11. No abstract available.

45.

Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes.

Sermet-Gaudelus I, Déchaux M, Vallée B, Fajac A, Girodon E, Nguyen-Khoa T, Marianovski R, Hurbain I, Bresson JL, Lenoir G, Edelman A.

Am J Respir Crit Care Med. 2005 May 1;171(9):1026-31. Epub 2005 Feb 11.

PMID:
15709055
46.

Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients.

Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, London GM, Jungers P.

Am J Kidney Dis. 2005 Jan;45(1):39-47.

PMID:
15696442
47.

Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.

Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, Phan O, Daudon M, Lacour B, Drüeke TB, Muntzel MS.

J Am Soc Nephrol. 2005 Jan;16(1):109-16. Epub 2004 Nov 24.

48.

[Evaluation of lipoperoxidation in hemodialysis patients with a simple test using the "Free Oxygen Radical Monitor"].

Dortet L, Nguyen-Khoa T, Kebede M, Coulloc'h J, Massy Z, Lacour B.

Ann Biol Clin (Paris). 2004 Nov-Dec;62(6):707-11. French.

49.

Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers.

Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, Cardoso C, Noël LH, Guérin AP, London GM, Jungers P.

Kidney Int. 2004 Oct;66(4):1606-12.

50.

Could proteinuria evaluation be helpful in predicting renal progression in apolipoprotein E-deficient (E-/-) mice with chronic renal failure?

Ivanovski O, Nguyen-Khoa T, Phan O, Massy ZA.

Nephrol Dial Transplant. 2004 Apr;19(4):1013-4; author reply 1014. No abstract available.

PMID:
15031372

Supplemental Content

Loading ...
Support Center